Galina S. Golosnaya

Galina S. Golosnaya

Auto-generated profile, based on publicly available information

Galina S. Golosnaya

N.N. Burdenko Voronezh State Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
KVK. V. Voronkova
K. V. Voronkova
GGG. S. Golosnaya
G. S. Golosnaya
ILI. D. Lemeshko
I. D. Lemeshko
APArray S. Petrukhin
Array S. Petrukhin
Pharmacotherapy of epilepsy requires deep knowledge of anti-epileptic drugs (AEDs), including the following issues: spectrum of therapeutic efficacy and therapeutic strength, adverse effects (especially severe and life-threatening adverse reactions); specific features of pharmacokinetics, pharmacodynamics, and drug interactions; titration rate, the need for laboratory tests during treatment, pharmacoeconomic components. The main properties of antiepileptic drugs are defined by their mechanisms of action. Today, particular attention is paid to the drugs with broad spectrum activity, which give an ability to use them in patients with so-called undifferentiated epilepsies. In this article, the authors describe their own experience in optimization of antiepileptic therapy in a group of 141 patients with various forms of epilepsy. This new optimized strategy implies inclusion of modern broad spectrum AEDs in treatment schemes along with the reduction in use of narrow spectrum drugs. Moreover, polytherapy was used in most of the cases after treatment regimen correction. All the measures allowed to achieve remission in about half of the patients with epilepsy earlier considered as incurable.

3 July 2020 in Russian Pediatric Journal
Verified
Journal Article
Open access
OKOlga N. Krasnorutskaya
Olga N. Krasnorutskaya
GGGalina S. Golosnaya
Galina S. Golosnaya
DBDaniil Yu. Bugrimov
Daniil Yu. Bugrimov
YKYuliya A. Kotova
Yuliya A. Kotova
MNMaksim Yu. Novikov
Maksim Yu. Novikov
AOAleksey V. Ogurtsov
Aleksey V. Ogurtsov
The study established a pattern of changes in neurovascular biomarkers in children who underwent perinatal hypoxia in order to optimize the prognosis of neurological disorders in children in the long term. Materials and methods. 419 patients aged 1 to 6 months were examined, 2 age groups 1-3 and 4-6 months were identified, the physical and psychomotor development of each subject was analyzed, and groups of mild, medium and severe forms of lesion were identified; a quantitative assessment of the biochemical markers of the neurovascular component of the pathogenesis of CNS lesion was carried out with the identification of the boundaries of the formation of processes. Results. The direct dependence of changes in indicators of biochemical markers on the degree of CNS damage was established.

30 November 2013 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
KVKira Vladimirovna Voronkova
Kira Vladimirovna Voronkova
OPO A Pylayeva
O A Pylayeva
AKA A Kholin
A A Kholin
GGG S Golosnaya
G S Golosnaya
TAT V Ananyeva
T V Ananyeva
APA S Petrukhin
A S Petrukhin
Проведено исследование, целью которого было изучение нейрофизиологических особенностей у пациентов с эпилепсией и аутизмом, а также определение эффективности антиэпилептической терапии. Наблюдалась группа из 113 пациентов в возрасте от 8 мес до 10 лет с аутистическими расстройствами. Все пациенты были разделены на 6 групп, 3 из которых состояли из пациентов с так называемым эпиаутизмом. В целом (n=113) наличие эпилептиформной активности в состоянии бодрствования было выявлено у 63% больных, из них у 45% обнаружены доброкачественные эпилептиформные разряды детства (ДЭРД), которые регистрировались, как и эпилептиформная активность во сне, у всех пациентов с эпиаутизмом. Выявлено существенное нарастание индекса эпиактивности во сне по сравнению с бодрствованием у 94% пациентов. В целом (n=113) при записи ЭЭГ во время сна у 71% больных выявлялась эпилептиформная активность, из них ДЭРД были зарегистрированы у 73%, что на 26% больше, чем в состоянии бодрствования. Во сне отмечалось нарастание представленности мультирегиональной активности. Эпилептиформная активность чаще выявлялась в центрально-височных отведениях. Основной составляющей терапии у наблюдавшихся пациентов являлся вальпроат в моно- и комбинированной терапии. Кроме того, назначались леветирацетам, этосуксимид и другие антиэпилептические препараты. После оптимизации терапии у большинства пациентов отмечалась редукция эпиактивности на ЭЭГ, однако нарушения в высшей психической сфере сохранялись.

15 April 2023 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
GGG. S. Golosnaya
G. S. Golosnaya
OKO. N. Krasnorutskaya
O. N. Krasnorutskaya
NEN. A. Ermolenko
N. A. Ermolenko
DKD. A. Kholichev
D. A. Kholichev
AOA. V. Ogurtsov
A. V. Ogurtsov
Background. Vasculoendothelial growth factor (VEGF) is responsible for vascular remodeling, influences the formation of post-hypoxic structural changes in the newborn brain and is synergistically closely related to neurotrophic factors, being an inhibitor of apoptosis processes, which are important for lesions of the central nervous system in newborns of various types of gestational age, having suffered both acute asphyxia at birth and chronic intrauterine hypoxia. VEGF has been little studied in premature newborns, which are at high risk for the formation of intraventricular hemorrhage and periventricular leukomalacia.Aim. To study changes in the serum concentration of VEGF, its role in the pathogenesis of severe hypoxic-ischemic lesions of the central nervous system in premature newborns of various gestational ages, as well as to determine its prognostic significance for the formation of severe structural brain lesions.Materials and methods. We observed 120 children with a gestational age from 25 to 36 weeks. The children were divided into 4 groups according to changes to neurosonography data. Determination of protein level was carried out by enzyme immunoassay.Results and conclusion. With the formation of ischemic and combined (intraventricular hemorrhage and periventricular leukomalacia) forms of post-hypoxic changes in the brain in newborns, by 5–7th days of life the concentration of VEGF significantly decreased compared to the test on the 1st day of life, and by the 4th week of life it decreased in 4 times in case of combined lesions. VEGF cannot be used as a marker of damage in the acute period (up to 5 days of life), since its initial levels in the blood serum do not differ significantly from those in the control group. However, a decrease in its concentration by the end of the 1st week of life makes it possible to reliably predict the formation of post-hypoxic changes in the brain. A decrease in the level of VEGF in the blood serum in premature newborns with structural changes according to neurosonography by the 4th week of life coincides with the timing of the formation of gliotic changes, which significantly affects the developmental prognosis of the examined children

15 July 2022 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
GGG. S. Golosnaya
G. S. Golosnaya
TBT. N. Belousova
T. N. Belousova
MNM. Yu. Novikov
M. Yu. Novikov
NKN. Yu. Knyazeva
N. Yu. Knyazeva
DPD. Yu. Podkopaev
D. Yu. Podkopaev
ЯГЯ. Я. Гинен
Я. Я. Гинен
Inherited metabolic disorders have a specific place among cases of sudden deterioration of the newborn’s condition. Therapies have been developed for some of these disorders. Accurate verification of the diagnosis is extremely important for choosing an optimal treatment strategy. However, treatment is not always successful due to the rapid progression of symptoms. We report a case of citrullinemia diagnosed in a newborn in Vidnoye Perinatal Center.

15 April 2024 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
GGG. S. Golosnaya
G. S. Golosnaya
OKO. N. Krasnorutskaya
O. N. Krasnorutskaya
NEN. A. Ermolenko
N. A. Ermolenko
VEV. L. Efimova
V. L. Efimova
TLT. A. Larionova
T. A. Larionova
MTM. D. Tysyachina
M. D. Tysyachina
The etiology of cerebral palsy in children with intrauterine hypotrophy at birth and developmental delay is often explained by chronic intrauterine hypoxia. However, children with muscle hypotonia and developmental delay require genetic examination. The aim of this study is to report a case of mitochondrial disease caused by FBXL4 gene mutations and to identify main diagnostic criteria for mitochondrial DNA (mtDNA) depletion syndromes (MDS) in early childhood. Mitochondrial DNA depletion syndrome-13 is associated with FBXL4 gene mutations located in the 6q16.1–q16.27 locus. This disorder was first described in 2013 by P.E. Bonnen and X. Gai independently. MDS are a clinically and genetically heterogeneous group of diseases inherited by an autosomal recessive type and caused by mutations in genes that support the biogenesis and integrity of mtDNA. Encephalomyopathic mtDNA depletion syndrome-13 (MTDPS13) (OMIM: 615471) is an exceedingly rare autosomal recessive disease caused by biallelic mutations in the FBXL4 gene (MIM: 605654) with an estimated prevalence of 1 case per 100,000– 400,000 newborns. The disease onset is usually observed in the neonatal period; 75 % of patients develop symptoms by the age of 3 months. In the majority of cases, mtDNA depletion syndrome-13 manifests itself in the early neonatal period; however, in some patients, the disease onset was registered by the age of 24 months. The disease is characterized by encephalopathy, hypotension, lactic acidosis, severe developmental delay, and changes in the area of basal ganglia revealed by magnetic resonance imaging of the brain. FBXL4-related encephalomyopathy is a multisystem disease primarily affecting the central nervous system, heart, and liver. It is characterized by different clinical manifestations such as lactic acidosis, developmental delay, generalized hypotension, nutritional disorders, and growth retardation. Some patients demonstrate specific facial features, including prominent forehead, sinus-shaped folds, thick eyebrows, long eyelashes, epicanthus, short eye slits, hypertelorism, wide and depressed nose bridge, long and smooth labial groove, thin upper lip, and low-set ears. The disease prognosis is extremely poor; most children die before the age of 4 years. Approximately half of the patients suffer from microcephaly and hyperammonemia. The outcome varies; death was reported in 30 % of cases. Mean time to death was 3 years (median – 2 years). The diagnosis is crucial for medical and genetic counseling and possible prenatal diagnosis.